Advertisement

Symptome, Befunde und Krankheiten unter umweltmedizinischem Aspekt

  • Andreas Beyer
  • Dieter Eis
Chapter

Zusammenfassung

Endokrine Disruptoren sind Stoffe, die das Hormonsystem in vielfältiger Weise beeinflussen können. Am besten untersucht ist der Einfluß von estrogenartig wirkenden Substanzen auf die Reproduktion, aber auch auf die Tumorentstehung gibt es eine nachweisbare Wirkung. Allerdings können auch andere Hormonsysteme, wie beispielsweise das Schilddrüsenhormon-system, durch endokrine Disruptoren in ihrer Funktionsweise verändert werden. Bei welchen Substanzen bislang eine Wirkung auf das Hormonsystem nachgewiesen werden konnte und wie vielfältig diese Stoffe in die Regelkreise eingreifen, erfahren Sie in dem folgenden Beitrag.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. [1]
    Kavlock R.J., et al. (1996): Research needs for risk assessment of health and environmental effects of endocrine disruptors: A report of the U.S. EPA-sponsored workshop. Environ. Health Perspect. 104, 715–740. Google Scholar
  2. [2]
    Cook J.W., Dodds E.C., Hewett C.L. (1933): A synthetic oestrus-exciting compound. Nature 131, 56. Google Scholar
  3. [3]
    Dodds E.C. & Lawson W. (1936): Synthetic estrogenic agents without the phenanthrene nucleus. Nature 137, 996. Google Scholar
  4. [4]
    Dodds E.C., Golberg L., Lawson W., Robinson R. (1938): Oestrogenic activity of certain synthetic compounds. Nature 141, 247–248. Google Scholar
  5. [5]
    Tullner W.W. (1961): Uterotrophic action of the insecticide methoxychlor. Science 133, 647–648. Google Scholar
  6. [6]
    Bitman J., Cecil H.C., Harris S.J., Fries G.F. (1968): Estrogenic activity ofo,p’-DDT in mammalian uterus and avian oviduct. Science 162, 371–372. Google Scholar
  7. [7]
    Bitman J. & Cecil H.C. (1970): Estrogenic activity of DDT analogs and polychlorinated biphenyls. J. Agr. Food Chem. 18, 1108–1112. Google Scholar
  8. [8]
    Fry D.M. & Toone C.K. (1981). DDT-induced feminization of gull embryos. Science 213, 922–924. Google Scholar
  9. [9]
    Soto A.M., Justicia H., Wray J.W., Sonnenschein C. (1991): p-nonyl-phenol: an estrogenic xenobiotic released from »modified« polystyrene. Environ. Health Perspect. 92, 167–173. Google Scholar
  10. [10]
    Soto A.M., Lin T.-M., Justicia H., Silvia R.M., Sonnenschein C. (1992): An »in culture« bioassay to assess the estrogenicity of xenobiotics (E-screen). In: Chemically-induced alterations in sexual and functional development: the wildlife/human connection (T. Colborn, C. Clement, eds.). Princeton NJ: Princeton Scientific Publishing, 295–309. Google Scholar
  11. [11]
    Soto A.M., Chung K.L., Sonnenschein C. (1994): The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. Environ. Health Perspect. 102, 380–383. Google Scholar
  12. [12]
    Soto A.M., Sonnenschein C., Chung K.L., Fernandez M.F., Olea N., Olea-Serrano M.F. (1995): The E-Screen assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ. Health Perspect. 103 Suppl. 7, 113–122. Google Scholar
  13. [13]
    Jobling S., Reynolds T., White R., Parker M.G., Sumpter J.P. (1995): A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ. Health Perspect. 103, 582–587. Google Scholar
  14. [14]
    Klotz D.M., Beckman B.S., Hill S.M., McLachlan J.A., Walters M. R., Arnold S.F. (1996): Identification of environmental chemicals with estrogenic activity using a combination of in vitro assays. Environ. Health Perspect. 104, 1084–1089. Google Scholar
  15. [15]
    Sharpe R.M., Fisher J.S., Millar M.M., Jobling S., Sumpter J.P. (1995): Gestational and lactational exposure of rats to xenoestrogens results in reduced testicular size and sperm production. Environ Health Persp. 103, 1136–1143. Google Scholar
  16. [16]
    Gimeno S., Gerritsen A., Bowmer T., Komen H. (1996): Feminization of male carp. Nature 384, 221–222. Google Scholar
  17. [17]
    Jobling S., Sheahan D., Osborne J.A., Matthiessen P., Sumpter J.P. (1996): Inhibition of testicular growth in rainbow trout (Oncorhynchus mykiss) exposed to estrogenic alkylphenolic chemicals. Environ. Toxicol. Chem 15, 194–202. Google Scholar
  18. [18]
    Ramsdell H.S., Blandin D.A., Schmechel T.R. (1996): Developmental effects and biochemical markers of alkylphenol exposure in frog larvae. Proceedings, 17 Annual Meeting of the Society of Environmental Toxicology and Chemistry, Washington, DC, November 17–21, p 140. Google Scholar
  19. [19]
    Allen E. & Doisy E.A. (1923): JAMA 81, 819 Google Scholar
  20. [20]
    Routledge E.J. & Sumpter J. P. (1996): Estrogenic activity of surfactants and some of their degradation products assessed using a recombinant yeast screen. Environ. Toxicol. Chem. 15, 241–248. Google Scholar
  21. [21]
    Körner W., Hanf V., Schuller W., Bartsch H., Zwirner M., Hagenmaier H. (1998): Validation and application of a rapid in vitro assay for assessing the estrogenic potency of halogenated phenolic chemicals. Chemosphere 37, 2395–2407. Google Scholar
  22. [22]
    Hackenberg R., Lüttchens S., Hofmann J., Kunzmann R., Hölzel F. and Schulz K.-D. (1991): Androgen sensitivity of the new human breast cancer cell line MFM-223. Cancer Res. 51, 5722–5727. Google Scholar
  23. [23]
    Körner W., Hanf V., Oettling G., Schuller W., Hagenmaier H. (1997): Effects of tris(4-chlorophenyl)methanol on proliferation of human breast cancer cells. Organohalogen Compounds 34, 364–369. Google Scholar
  24. [24]
    Szelei J., Jimenez J., Soto A.M., Luizzi M.F., Sonnenschein C. (1997): Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor. Endocrinology 138, 1406–1412. Google Scholar
  25. [25]
    Kelce W.R., Monosson E., Gamcsik M.P., Laws S.C., Gray Jr. L.E. (1994): Environmental hormone disruptors: Evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicol. Appl. Pharmacol. 126, 276–285. Google Scholar
  26. [26]
    Hertz R. (1985): The estrogen problem retrospect and prospect. In: Estrogens in the Environment II — Influences on Development (McLachlan J.A., ed). New York: Elsevier, 1–11. Google Scholar
  27. [27]
    Gellert R.J. (1978): Kepone, Mirex, dieldrin, and aldrin: estrogenic activity and the induction of persistent vaginal estrus and anovulation in rats following neonatal treatment. Environmental Research 16, 131–138. Google Scholar
  28. [28]
    Gellert R.J. (1978): Uterotrophic activity of polychlorinated biphenyls (PCB) and induction of precocious reproductive aging in neonatally treated female rats. Environmental Research 16, 123–130. Google Scholar
  29. [29]
    Loeber J.G. & Van Velsen F.L. (1984): Uterotropic effect of b-HCH, a food chain contaminant. Food Addit. Contam. 1, 63–66. Google Scholar
  30. [30]
    Wester P.J., Canton J.H., Bisschop A. (1985): Histopathological study of Poecilia reticulata (guppy) after long-term β-hexachloro-cyclohexane exposure. Aquat. Toxicol. 6, 271–296. Google Scholar
  31. [31]
    Gupta P.K. & Gupta R.C. (1979): Pharmacology, toxicology and degradation of endosulfan. A review. Toxicology 13, 115–130. Google Scholar
  32. [32]
    Singh S.K. & Pandey R.S. (1990): Effect of sub-chronic endosulfan exposures on plasma gonadotropins, testosterone, testicular testosterone and enzymes of androgen biosynthesis in rat. Ind. J. Exp. Biol. 28, 953–956. Google Scholar
  33. [33]
    Wine R.N., Li L.-H., Hommel Barnes L., Gulati D.K., Chapín R.E. (1997): The reproductive toxicity of di-n-butylphthalate in a continuous breeding protocol in Sprague-Dawley rats. Environ. Health Perspect. 105, 102–107. Google Scholar
  34. [34]
    Sharpe R.M., Turner K.T., Sumpter J.P. (1998): Endocrine disruptors and testis development. Environ Health Persp. 106, A220–A221. Google Scholar
  35. [35]
    Schuller W. (1998): Etablierung und praktische Anwendung eines Testsystems mit humanen Brustkrebszellinien zum Nachweis estrogenartiger Wirkungen (E-Screen-Assay). Dissertation. Universität Tübingen, Fakultät für Biologie. Google Scholar
  36. [36]
    Soto A.M., Sonnenschein C., Murray M.K., Michaelson G.L. (1998): Estrogenic plasticizers and antioxidants. In: Eisenbrand G. et al. (eds). Hormonally active agents in food: symposium / Deutsche Forschungsgemeinschaft. Wiley-VCH, Weinheim, S. 142–160. Google Scholar
  37. [37]
    Harries C.A., Henttu P., Parker M.G., Sumpter J.P. (1997): The estrogenic activity of phthalate esters in vitro. Environ. Health Perspect. 105, 802–811. Google Scholar
  38. [1]
    Aeschlimann A., Graf U., Bourgeois P.: Umweltchemikalien: ihre klinische Bedeutung in der Rheumatologie. Schweiz. Rundschau Med, 80, Nr. 43: 1190–1196, 1991. Google Scholar
  39. [2]
    Bourgeois P., Aeschlimann A., Bourgeois-Drouin C.: Sclérodermies. In: Traité des maladies systémiques. Kahn M. F.; Peltier A.P.; Meyer O., Piette J. E.(éds.). 3. éd. Flammarion Médecine-Science, Paris, 4 (R press) Google Scholar
  40. [3]
    Bourgeois P., Elleuch M., Barranquero A.: Sclérodermies et autres connectivites induites non médicamenteuses. In: L’actualité rhumatologique. de Sèze S., Ryckewaert A., Kahn M.F., Guérin C. (éds.). Expansion scientifique francaise, Paris, 54–63, 1985. Google Scholar
  41. [4]
    Aeschlimann A., de Truchis P., Kahn M. F.: Scleroderma after therapy with appetite suppressants. Reports on four cases. Scand. J. Rheumatol. 19: 87–90, 1990. Google Scholar
  42. [5]
    Bourgeois P., Aeschlimann A.: Drug-induced scleroderma. In: Drug-induced rheumatic diseases. Baillière’s Clinical Rheumatology 5: 13–20, 1991. Google Scholar
  43. [6]
    Straniero N. R., Furst D. E.: Environmentally induced systemic sclerosis-like illness. In: Occupational rheumatic diseases. Balint G. P., Buchanan W. W. (eds.), Baillières. Clinical Rheumatology 3: 63–79, 1989. Google Scholar
  44. [7]
    Alozo-Ruiz A., Zea-Mendoza A. C., Salazar-Vallinas J. M.: Toxic oil syndrome: A syndrome with features overlapping those from various forma of scleroderma. Sem. Arthritis Rheum. 15 [3]: 200–221, 1986. Google Scholar
  45. [8]
    Shulman L. E.: The eosinophilia-myalgia syndrome associated with ingestion of ¿-Tryptophan. Editorial Arthritis Rheum. 33: 913–917, 1990. Google Scholar
  46. [9]
    Gilsanz V., Lopez Alvarez J. D., Serrano S.: Evolution of the alimentary toxic oil syndrome due to ingestion of denaturated rapeseed oil. Arch. Int. Med. 144: 254–265, 1984. Google Scholar
  47. [10]
    Tabuenca J. M.: Toxic-allergic syndrome with aniline. Lancet II: 567–568, 1981. Google Scholar
  48. [11]
    Pestana A., Munoz E.: Anilides and the Spanish toxic oil syndrome. Nature 298: 608, 1982. Google Scholar
  49. [12]
    Vicario J. L., Serrano Rios M., San Andres F., Arnais Villena A.: HLA DR3, DR4 increase in chronic stage of Spanish oil disease. Lancet I: 276, 1982. Google Scholar
  50. [13]
    von Schonfeld J., Breuer N.: Vinylchlorid und Hamangiosarkom der Leber. Med. Klin., Sept 15; 86 [9]: 482–484, 1991. Google Scholar
  51. [14]
    Wilson R. H., McCormick W., E., Tatum C. F.: Occupational acroosteolysis. Report of 31 cases. J. Am. Med. Ass. 201: 577–581, 1967 Google Scholar
  52. [15]
    Veltman G., Lange C. E., Juhe S., Stein G., Bachner V.: Clinical manifestations and course of vinyl chlorid disease. Ann. N. Y. Acad. Sci. 246: 6–17, 1975. Google Scholar
  53. [16]
    Ward A. M., Udnoon S., Watkins J.: Immunological mechanisms in the pathogenesis of vinyl chlorid disease. Br. Med. f. 1: 936–938, 1976. Google Scholar
  54. [17]
    Black O. M., Welch K. I., Walcker A. E., Bernstein R. M., Catoggio L. J., McGregor, A. R., Jones J. K. L.: Genetic susceptibility to scleroderma-like syndrom induced by vinyl chlorid. Lancet I: 53–63, 1983. Google Scholar
  55. [18]
    Yamakage A., Ishikawa H.: Generalized morphea-like scleroderma occuring in people exposed to organic solvents. Dermatologica 165: 186–193, 1982. Google Scholar
  56. [19]
    Nietert P. J., Sutherland S. E., Silver R. M., Pandey J. P., Knapp R. G., Hoel D. G., Dosemeci M.: Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum, Vol 41, No. 6: 1111–1118, June 1998. Google Scholar
  57. [20]
    Sparrow G. P.: A connective tissue disorder similar to vinyl chlorid disease in a patient expose to perchlorethylene. Clin. Exp. Dermatol. 2: 17–22, 1977. Google Scholar
  58. [21]
    Bolt H., Filser J.: Irreversible binding of chlorinated ethylenes to macromolecules. Environ Health Perspect, 21: 107–112, 1977 Google Scholar
  59. [22]
    Rocci P., Prodi G., Grilli S., Ferreri A.: In vivo and in vitro binding of carbon tetrachloride with nucleic acids and proteins in rat and mouse liver. Int. J. Cancer, 11: 419–425, 1973. Google Scholar
  60. [23]
    Khan M., Kaphalia B., Prabhakar B., Kanz M., Ansari G.: Trichloroethylene-inducedautoimmune response infernale MRL +/+ mice. Toxicol. Appl. Pharmacol., 134: 155–160, 1995. Google Scholar
  61. [24]
    Byers V., Levin A., Ozonoff D., Baldwin R.: Association between clinical symptoms and lymphocyte abnormalities in a population with chronic domestic exposure to industrial solvent-contaminated domestic water supply and a high incidence of leukaemia. Cancer Immunol. Immunother, 27: 77–81, 1988. Google Scholar
  62. [25]
    Walder B. K.: Do solvents cause scleroderma? Int. J. Derm. 22: 157, 1983. Google Scholar
  63. [26]
    Czirjak L., Szegedi G.: Benzene exposure and systemic sclerosis (letter). Ann. Intern. Med. 107: 118, 1987. Google Scholar
  64. [27]
    Yamakage A., Ishikawa H., Saito Y., Hattori A.: Occupational scleroderma-like disorder occuring in men engaged in the polymerization of epoxy resins. Dermatologica 161: 33–34, 1980. Google Scholar
  65. [28]
    Thorgeirsson A., Fregert S., Ramnas O.: Sensitization capacity of epoxy resin oligomers in the Guinea pig. Acta Derm. Vener. 58: 17–21, 1978. Google Scholar
  66. [29]
    Erasmus L. D.: Scleroderma in gold-miners on the Witwatersand with Particular reference to pulmonary manifestations. South Afr. J. Clin. Med. 3: 209–231, 1957. Google Scholar
  67. [30]
    Rodnan G. P., Benedek T. G., Medsger T. A.: The association of progressive systemic sclerosis (scleroderma) with coal miner’s pneumoconiosis and other forms of silicosis. Ann. Int. Med. 66:323–334, 1966 Google Scholar
  68. [31]
    Conrad K., Levy Y., Blank M., Mehlhorn J., Frank K. H., Roch B., Shoenfeld Y.: The pathogenic 16/6 idiotype in patients with silica associated systemic lupus erythematosus and uranium miners with increased risk for development of SLE. J Rheum 2514:, 660–666, 1998. Google Scholar
  69. [32]
    Wiethege Th.: Expression von TNF alpha in Alveolarmakrophagen nach Stimulation mit Quarzstaub, Schweissrauchstaub und Asbestfasern. Pneumologie 46: 621–625, 1992. Google Scholar
  70. [33]
    Reiser K. M., Last J. A.: Silicosis and fibrogenesis: fact and artefact. Toxicology 13: 51–72, 1979. Google Scholar
  71. [34]
    Rihs H. P., Conrad K., Mehlhorn J., May-Taube K, Welticke B, Frank K. H., Baur X.: Untersuchungen über die Assoziation zwischen HLA-D-Allelen und dem Auftreten sklerodermietypischer Autoantikörper unter quarzstaubexponierten Personen. Z. ärztl. Fortbild. 88: 513–518, 1994. Google Scholar
  72. [35]
    Van Nunen S. A., Gatensby P. A., Basten A.: Post-mammoplasty connective tissue disease. Arhtritis Rheum. 25: 694–697, 1982. Google Scholar
  73. [1]
    Tretter F.(1993) Umweltmedizin und Humanökologie. In: Aurand K, Hazard B.P., Tretter F. (Hrsg). Umweltbelastungen und Ängste. Erkennen, Bewerten, Vermeiden. Opladen: Westdeutscher Verlag, 28–50. Google Scholar
  74. [2]
    Lazarus R.S., Lounier R.(1978) Stress related transactions between person and environment. In: Pervin L., Lewis M. (eds) Perspectives in Interactional Psychology. Plenum Press New York, 287–327 Google Scholar
  75. [3]
    Ruff F.M. (1993) Risikokommunikation als Aufgabe fur die Umweltmedizin. In: Aurand K., Hazard B.P. Tretter F. (Hrsg). Umweltbelastungen und Ängste. Erkennen, Bewerten, Vermeiden. Opladen: Westdeutscher Verlag, 327–364. Google Scholar
  76. [4]
    Nix W. (1996) MCS/IEI und CFS: Diagnose multiple-chemical-sensitivity und chronic fatique syndrome. Bewertung des Symptoms »Erschöpfbarkeit«. Umweltmedizin in Forschung und Praxis 1: 229–238 Google Scholar
  77. [5]
    Pennebaker J. (1994) Psychological bases of symptom reporting: perceptual and emotional aspects of chemical sensitivity. Toxicol Ind Health 10: 497–511 Google Scholar
  78. [6]
    Staudenmayer H., Selner M., Selner J. (1993) Adult sequelae of childhood abuse presenting environmental illness. Ann Allergy 71: 538–546 Google Scholar
  79. [7]
    Reko K. (1984) The psychosocial impact of environmental disasters. Bull Environ Contam Toxicol 1984, 655–661. Google Scholar
  80. [8]
    Horowitz M. (1983) Psychological response to serious life events. In: Breznitz S. (editor) The Denial of Stress. New York: International Universities Press, 129–160. Google Scholar
  81. [9]
    Richter H.E. (1989) Die Bedeutung der Psychologie in der Medizin. Psychother med Psychol 39:51–57 Google Scholar
  82. [10]
    Petri H. (1991) Zur Psychoanalyse der vergifteten Kindheit. Psychother med Psychol 1991, 155–165. Google Scholar
  83. [11]
    Richter H.E. (1990) Der schwierige Weg einer kritischen Psychosomatik. Psychother med Psychol 40:318–323. Google Scholar
  84. [12]
    Vyner H.M. (1988) Invisible trauma. Toronto: Lexington Books Massachusetts Google Scholar
  85. [13]
    Foulks E., McLellen T. (1992) Psychological sequelae of chronic toxic waste exposure. Southern Medical Journal 85:122–126. Google Scholar
  86. [14]
    Edelstein M. (1988) Contaminated Communities. The social and psychological impacts of residential toxic exposure. Boulder & London: Westview Press Google Scholar
  87. [15]
    Schimmelpfennig W. (1996) Umweltbedingte Gesundheitsstörungen. Umweltmedizin in Forschung und Praxis 1: 211–213 Google Scholar
  88. [16]
    Cullen M. (1987) The worker with multiple chemical hypersensitivities: an overview. Occup Med State Art Rev 2: 655–661 Google Scholar
  89. [17]
    Workshop zu Multiple Chemical Sensitivities (MCS) (1996) Bericht der IPCS (International Program on Chemical Safety). Unveröffentlicht. Google Scholar
  90. [18]
    Fukuda K., Straus S.E., Hickie I., Sharpe M., Dobbins Y., Kumaroff A. (1994) The Chronic Fatigue Syndrome. A comprehensive approach to its definition, and study. Ann Intern Med 121: 953–959 Google Scholar
  91. [19]
    Brodsky C. (1987) Multiple chemical sensitivities and other environmental illness: a psychiatrists view. In: Cullen M. (ed) Workers with multiple chemical sensitivities. Occup Med State Art Rev. Philadelphia: Henley & Belfus 2: 695–704 Google Scholar
  92. [20]
    Terr A. (1986) Environmental illness. Arch Intern Med 146: 145–149 Google Scholar
  93. [21]
    Sparks P., Simon G., Katon W., Altman L., Ayars G, Johnson R (1990) An outbreak of illness among aerospace workers. West J Med 153: 28–33 Google Scholar
  94. [22]
    Fiedler N., Kipen H., DeLuca J., Kelly Mc Neil K., Natelson B. (1996) A controlled comparison of multiple chemical sensitivities and chronic fatigue syndrome. Psychosom Med 58: 38–49 Google Scholar
  95. [23]
    Black D., Rathe A., Goldstein R. (1990) Environmental illness.- A controlled study of 26 subjects with »20th century disease«. JAMA 264: 3166–3170 Google Scholar
  96. [24]
    Simon G.E., Wayne J.K., Sparks P.J. (1990) Allergic to life: Psychobgical factors in environmental illness. Am J Psychiatry 117: 901–906 Google Scholar
  97. [25]
    Malt Li., Nerdrum P., Oppedal B., Gundersen R., Holte M., Löne J. (1997) Physical and mental problems attributed to dental amalgam fillings: a descriptive study of 99 self-referred patients compared with 272 controls. Psychosom Med 59: 32–41 Google Scholar
  98. [26]
    Terr A. (1989) Clinical ecology in the workplace. J Occup Med 31: 257–261 Google Scholar
  99. [27]
    Davidoff A., Keyl P. (1996) Symptoms and health in individuals with multiple chemical sensitivities syndrome from four reported sensitizing exposures and a general population comparison group. Arch Environ Health 51: 201–213 Google Scholar
  100. [28]
    Sparks P., Daniell W., Black D., Kipen H., Altman L., Simon G., Terr A. (1994) Multiple chemical sensitivity syndrome: A clinical perspective. J Occup Med 36: 718–737 Google Scholar
  101. [29]
    Weiner H. (1983) Gesundheit, Krankheitsgefühl und Krankheit; Ansätze zu einem integrativen Verständnis. Psychother Med Psychol 33: 15–34 Google Scholar
  102. [30]
    Küchenhoff J. (1994) Spezifitätsmodelle in der psychosomatischen Medizin; Rückblick auf eine alte Kontroverse. Zeitschr Psychosom Medizin und Psychoanalyse 40: 236–248 Google Scholar
  103. [31]
    Plassmann R. (1997) Psychosomatische Erkrankungen auf dem Gebiet der Umweltmedizin. Zeitschrift fur Ärztliche Fortbildung. Qualitätssicherung 91: 43–49 Google Scholar
  104. [32]
    Gieler U., Bullinger M., Behrendt H. et al (1998) Therapeutische Aspekte des multiple chemical sensitivity Syndroms. Umweltmedizin in Forschung und Praxis 3: 3–10 Google Scholar
  105. [33]
    Schüffel W., Hermann J.M., Dahme B., Richter R. (1990) Asthma bronchiale. In: von Uexküll T (Hrsg). Psychosomatische Medizin. München Wien Baltimore: Urban & Schwarzenberg, 745–760. Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • Andreas Beyer
    • 1
  • Dieter Eis
    • 2
  1. 1.Berlin-SteglitzDeutschland
  2. 2.Robert-Koch-InstitutBerlinDeutschland

Personalised recommendations